跳转至内容
Merck
CN

93361

TAPS

BioUltra, ≥99.5% (T)

别名:

N-[三(羟甲基)甲基]-3-氨基丙磺酸, [(2-羟基-1,1-二(羟甲基)乙基)氨基]-1-丙磺酸

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C7H17NO6S
化学文摘社编号:
分子量:
243.28
EC Number:
249-954-1
UNSPSC Code:
12161700
PubChem Substance ID:
Beilstein/REAXYS Number:
2452420
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


product line

BioUltra

assay

≥99.5% (T)

impurities

insoluble matter, passes filter test

ign. residue

≤0.1% (as SO4)

pH

4.5-6.5 (25 °C, 0.1 M in H2O)

useful pH range

7.7-9.1

pKa 

8.4

mp

230-235 °C (dec.)

solubility

H2O: 0.1 M at 20 °C, clear, colorless

anion traces

chloride (Cl-): ≤50 mg/kg, sulfate (SO42-): ≤50 mg/kg

cation traces

Al: ≤5 mg/kg, As: ≤0.1 mg/kg, Ba: ≤5 mg/kg, Bi: ≤5 mg/kg, Ca: ≤10 mg/kg, Cd: ≤5 mg/kg, Co: ≤5 mg/kg, Cr: ≤5 mg/kg, Cu: ≤5 mg/kg, Fe: ≤5 mg/kg, K: ≤50 mg/kg, Li: ≤5 mg/kg, Mg: ≤5 mg/kg, Mn: ≤5 mg/kg, Mo: ≤5 mg/kg, Na: ≤50 mg/kg, Ni: ≤5 mg/kg, Pb: ≤5 mg/kg, Sr: ≤5 mg/kg, Zn: ≤5 mg/kg

λ

0.1 M in H2O

UV absorption

λ: 260 nm Amax: 0.012, λ: 280 nm Amax: 0.008

SMILES string

OCC(CO)(CO)NCCCS(O)(=O)=O

InChI

1S/C7H17NO6S/c9-4-7(5-10,6-11)8-2-1-3-15(12,13)14/h8-11H,1-6H2,(H,12,13,14)

InChI key

YNLCVAQJIKOXER-UHFFFAOYSA-N

Other Notes

用于研究叶绿体片层制备中的电子转移和磷酸化作用;在冷冻干燥期间为氧合血红蛋白提供充分的保护,使其免于氧化成高铁血红蛋白;结合柱上瞬间等速电泳预富集,通过毛细管区带电泳进行的蛋白质痕量分析中的背景电解质


Still not finding the right product?

Explore all of our products under TAPS


法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Hydrogen ion buffers.
N E Good et al.
Methods in enzymology, 24, 53-68 (1972-01-01)
F Foret et al.
Electrophoresis, 14(5-6), 417-428 (1993-05-01)
The qualitative and quantitative aspects of transient isotachophoretic (ITP) sample preconcentration in the capillary zone electrophoretic analysis of protein samples have been demonstrated. By the proper selection of components of the background electrolyte and/or additives to the sample solution, two
A Fauvel et al.
Journal of pharmaceutical sciences, 73(6), 784-787 (1984-06-01)
Hemoglobin was freeze-dried in the presence of salts of EDTA, sulfonic acids used as buffers, or derivatives of pantothenic acid. At 0.25 M most of the compounds effectively inhibited the formation of methemoglobin. The various model compounds used (sodium zinc